MPT Q3 2026 Earnings: Asset Sales Lift GAAP Profit as NFFO Falls

Medical Properties Trust (NYSE: MPT) reported Q3 2026 revenue of $250.1 million, up about 5.3% from $237.5 million a year earlier, while diluted EPS improved to $0.34 from a loss of $0.13. GAAP net income attributable to common stockholders reached $201.6 million, but normalized funds from operations declined as asset-sale and refinancing gains supported reported profit while HSA’s missed September rent weighed on normalized earnings.

Core Financial Results

Revenue growth came mainly from billed rent, which increased to $195.3 million from $181.0 million. Total expenses rose faster than revenue, however, increasing about 7.2% as interest expense climbed by $20.7 million to $153.1 million, partly offset by lower general and administrative expense.

GAAP and normalized performance diverged sharply. Real estate sale gains and a debt refinancing benefit helped MPT swing to a profit, while NFFO fell 17.4% to $63.8 million.

FFO and NFFO are supplemental REIT performance measures rather than substitutes for GAAP net income or operating cash flow.

Portfolio and Tenant Performance

MPT ended the quarter with approximately $14.4 billion of total assets, including $8.3 billion of general acute facilities, $2.4 billion of behavioral health facilities, and $1.6 billion of post-acute facilities. Its portfolio comprised 365 properties and about 37,000 licensed beds leased to or mortgaged by 52 hospital operators across nine countries.

During the quarter, MPT sold its remaining interest in five Utah hospitals for approximately $174 million and its interest in two Idaho hospital properties for approximately $371 million. Together with other transactions, asset sales generated approximately $680 million of Q3 cash proceeds and an aggregate gain of about $158 million.

Tenant performance remained a pressure point. HSA did not pay September rent because of continuing revenue-cycle management challenges, reducing quarterly NFFO by $0.02 per share. HSA engaged Ovation Healthcare to oversee portfolio operations and improve billing and collections, while MPT provided additional working-capital support during the quarter.

Profitability, Liquidity, and the Balance Sheet

MPT’s debt, net, declined to $9.26 billion at September 30, 2026, from $9.70 billion at December 31, 2025, a reduction of about 4.5%. Cash and cash equivalents increased to $599.3 million from $540.9 million over the same period.

The company completed an approximately $2.4 billion secured-note offering and used the proceeds to repay existing obligations, including its 2026 notes and approximately half of its 2027 notes. The transaction extended debt maturities and produced a $69.5 million refinancing benefit in the quarter. Because the new notes primarily replaced existing debt, the transaction was principally a maturity-management step rather than a debt reduction of the same amount.

The $680 million of asset-sale proceeds remained available for debt repayment and other balance-sheet improvements. MPT also paid a regular quarterly dividend of $0.09 per share in October 2026.

Asset Sale and Refinancing Gains Masked Weaker Normalized Earnings

The quarter’s GAAP profit was heavily influenced by non-recurring items. MPT recorded a $157.8 million gain on real estate sales and a $69.5 million debt refinancing benefit, compared with a real estate sale loss of $9.1 million and negligible refinancing costs a year earlier. These items helped total other income reach $225.8 million, versus a $58.0 million expense in Q3 2025.

The different treatment of those gains explains much of the gap among MPT’s earnings measures. Nareit FFO excludes real estate sale gains but still reflected the refinancing benefit, helping FFO rise to $143.4 million. NFFO then removed the refinancing benefit and other non-core adjustments, resulting in a decline to $63.8 million.

Recurring earnings also faced pressure from HSA’s missed rent and higher interest expense. Before other income, total expenses exceeded revenue by about $13.7 million, compared with approximately $8.6 million a year earlier. This makes rent collection and financing costs more important indicators of underlying performance than the quarter’s GAAP profit alone.

Guidance

MPT maintained its expectation for more than $1.0 billion of portfolio cash rents in 2027. The estimate incorporates the rental income lost through Q3 asset sales and uses conservative assumptions for cash-basis tenants, including HSA.

This expectation applies specifically to portfolio cash rents and is not full revenue or NFFO guidance.

Recent Insider Transactions

The detailed insider transaction list reported that officer James Kevin Hanna made a direct purchase on August 20, 2026. The disclosed price and transaction value imply a purchase of approximately 2,300 shares.

The other nine latest entries were zero-value stock grants rather than open-market purchases. The source’s six-month summary nevertheless showed zero purchases, which conflicts with the detailed transaction record.

Risks Investors Should Monitor

• HSA rent collection: HSA’s failure to pay September rent reduced NFFO by $0.02 per share. Continued collection difficulties could affect rental income and require further financial support from MPT.
• Interest and refinancing costs: Interest expense increased about 15.6% year over year, while reported debt remained $9.26 billion. Future earnings will remain sensitive to financing costs and the company’s ability to manage upcoming maturities.
• Asset-sale trade-offs: Dispositions generated cash and accounting gains but also removed rental income from the portfolio. MPT’s 2027 cash-rent expectation depends on the remaining portfolio and assumptions for cash-basis tenants.
• Normalized earnings pressure: NFFO declined despite higher revenue, showing that tenant payment issues and financing expenses can offset growth in billed rent.

Summary

MPT’s Q3 2026 results reflected two different trends: asset sales and refinancing actions produced a GAAP profit and improved near-term balance-sheet flexibility, while NFFO declined because of tenant collection issues and higher interest expense. The main items to monitor are HSA’s billing and rent recovery, further debt reduction from asset-sale proceeds, and whether the remaining portfolio can deliver more than $1.0 billion of cash rent in 2027.